The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Meta-analyses on prevalence of selected Parkinson's nonmotor symptoms before and after diagnosis
Open accessAbstract
BACKGROUND: Nonmotor symptoms are common among patients with Parkinson's disease (PD) and some may precede disease diagnosis. METHODS: We conducted a meta-analysis on the prevalence of selected nonmotor symptoms before and after PD diagnosis, using random-effect models. We searched PubMed (1965 through October/November 2012) for the following symptoms: hyposmia, constipation, rapid eye movement sleep behavior disorder, excessive daytime sleepiness, depression, and anxiety. Eligible studies were publications in English with original data on one or more of these symptoms. RESULTS: The search generated 2,373 non-duplicated publications and 332 met the inclusion criteria, mostly (n = 320) on symptoms after PD diagnosis. For all symptoms, the prevalence was substantially higher in PD cases than in controls, each affecting over a third of the patients. Hyposmia was the most prevalent (75.5% in cases vs. 19.1% in controls), followed by constipation (50% vs. 17.7%), anxiety (39.9% vs. 19.1%), rapid eye movement sleep behavior disorder (37.0% vs. 7.0%), depression (36.6% vs. 14.9%), and excessive daytime sleepiness (33.9% vs. 10.5%). We observed substantial heterogeneities across studies and meta-regression analyses suggested that several factors might have contributed to this. However, the prevalence estimates were fairly robust in several sensitivity analyses. Only 20 studies had data on any symptoms prior to PD diagnosis, but still the analyses revealed higher prevalence in future PD cases than in controls. CONCLUSION: These symptoms are common among PD patients both before and after diagnosis. Further studies are needed to understand the natural history of nonmotor symptoms in PD and their etiological and clinical implications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some of these symptoms may precede the classical motor symptoms by several years (Abbott et al., 2001;Chen et al., 2015;Gao et al., 2011)”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Chen et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
(2000) · Cited by 9,198
Barone, P., Antonini, A., Colosimo, C., Marconi, R., Morgante, L., Avarello, T. P., Bottacchi, E., Cannas, A., Ceravolo, G., Ceravolo, R., et al. (2009) · Movement Disorders · doi:10.1002/mds.22643 · Cited by 1,445
Prevalence of olfactory impairment in older adults.
Murphy, C. (2002) · JAMA · doi:10.1001/jama.288.18.2307 · Cited by 953
Suares, N. C., & Ford, A. C. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.164 · Cited by 919
Meta‐analysis of early nonmotor features and risk factors for Parkinson disease
Noyce, A. J., Bestwick, J. P., Silveira‐Moriyama, L., Hawkes, C. H., Giovannoni, G., Lees, A. J., & Schrag, A. E. (2012) · Annals of Neurology · doi:10.1002/ana.23687 · Cited by 834
Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder
Postuma, R. B., Gagnon, J., Vendette, M., Fantini, M. L., Massicotte-Marquez, J., & Montplaisir, J. Y. (2008) · Neurology · doi:10.1212/01.wnl.0000340980.19702.6e · Cited by 779
Association of olfactory dysfunction with risk for future Parkinson's disease
Ross, G. W., Petrovitch, H., Abbott, R. D., Tanner, C. M., Popper, J. S., Masaki, K., Launer, L. J., & White, L. R. (2007) · Annals of Neurology · doi:10.1002/ana.21291 · Cited by 739
Development of the 12‐Item Cross‐Cultural Smell Identification Test(CC‐SIT)
Doty, R. L., Marcus, A., & Lee, W. W. (1996) · The Laryngoscope · doi:10.1097/00005537-199603000-00021 · Cited by 734
Cited by
Sorted by citations
The gut microbiota–brain axis in behaviour and brain disorders
Morais, L. H., Schreiber, H. L., & Mazmanian, S. K. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00460-0 · Cited by 2,149
The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
Houser, M. C., & Tansey, M. G. (2017) · npj Parkinson's Disease · doi:10.1038/s41531-016-0002-0 · Cited by 588
Vagotomy and Parkinson disease: A Swedish register–based matched-cohort study
Liu, B., Fang, F., Pedersen, N. L., Tillander, A., Ludvigsson, J. F., Ekbom, A., Svenningsson, P., Chen, H., & Wirdefeldt, K. (2017) · Neurology · doi:10.1212/wnl.0000000000003961 · Cited by 447
Self-citationPeter, I., Dubinsky, M., Bressman, S., Park, A., Lu, C., Chen, N., & Wang, A. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0605 · Cited by 386
The gut microbiota–brain axis in neurological disorder
Ullah, H., Arbab, S., Tian, Y., Liu, C., Chen, Y., Li, Q., Khan, M. I. U., Hassan, I. U., & Li, K. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1225875 · Cited by 292
The vermiform appendix impacts the risk of developing Parkinson’s disease
Killinger, B. A., Madaj, Z., Sikora, J. W., Rey, N. L., Haas, A. J., Vepa, Y., Lindqvist, D., Chen, H., Thomas, P. M., Brundin, P., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar5280 · Cited by 287
Self-citationWallen, Z. D., Appah, M., Dean, M. N., Sesler, C. L., Factor, S. A., Molho, E., Zabetian, C. P., Standaert, D. G., & Payami, H. (2020) · npj Parkinson s Disease · doi:10.1038/s41531-020-0112-6 · Cited by 252
Constipation preceding Parkinson's disease: a systematic review and meta-analysis
Adams-Carr, K. L., Bestwick, J. P., Shribman, S., Lees, A., Schrag, A., & Noyce, A. J. (2016) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-311680 · Cited by 228
Microbiota Signaling Pathways that Influence Neurologic Disease
Cox, L. M., & Weiner, H. L. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0598-8 · Cited by 210
Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
Zhang, X., Tang, B., & Guo, J. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00392-8 · Cited by 212
The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies
Perez-Pardo, P., Kliest, T., Dodiya, H. B., Broersen, L. M., Garssen, J., Keshavarzian, A., & Kraneveld, A. D. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.042 · Cited by 203
Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease
Houser, M. C., Chang, J., Factor, S. A., Molho, E., Zabetian, C. P., Hill‐Burns, E. M., Payami, H., Hertzberg, V., & Tansey, M. G. (2018) · Movement Disorders · doi:10.1002/mds.27326 · Cited by 204
Manfredsson, F. P., Luk, K. C., Benskey, M. J., Gezer, A., Garcia, J., Kuhn, N. C., Sandoval, I. M., Patterson, J. R., O'Mara, A., Yonkers, R., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.01.008 · Cited by 199
Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities
Araújo, B., Caridade-Silva, R., Soares-Guedes, C., Martins‐Macedo, J., Gomes, E. D., Monteiro, S., & Teixeira, F. G. (2022) · Cells · doi:10.3390/cells11182908 · Cited by 209
Gut–brain axis and the spread of α‐synuclein pathology: Vagal highway or dead end?
Breen, D. P., Halliday, G. M., & Lang, A. E. (2019) · Movement Disorders · doi:10.1002/mds.27556 · Cited by 193
The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease
Yang, D., Zhao, D., Ali Shah, S. Z., Wu, W., Lai, M., Zhang, X., Li, J., Guan, Z., Zhao, H., Li, W., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01155 · Cited by 162
Bunker, A., & Róg, T. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.604770 · Cited by 162
Nair, A. T., Ramachandran, V., Joghee, N. M., Shanish Antony, A., & Ramalingam, G. (2018) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm17105 · Cited by 164
Probiotics for Parkinson’s Disease
Gazerani, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174121 · Cited by 156
Weis, S., Schwiertz, A., Unger, M. M., Becker, A., Faßbender, K., Ratering, S., Kohl, M., Schnell, S., Schäfer, K.-H., & Egert, M. (2019) · npj Parkinson s Disease · doi:10.1038/s41531-019-0100-x · Cited by 145
“LRRK2: Autophagy and Lysosomal Activity”
Madureira, M., Connor‐Robson, N., & Wade‐Martins, R. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00498 · Cited by 143
Parkinson's disease: convergence on synaptic homeostasis
Soukup, S., Vanhauwaert, R., & Verstreken, P. (2018) · The EMBO Journal · doi:10.15252/embj.201898960 · Cited by 131
Gut microbiome and Parkinson's disease: Perspective on pathogenesis and treatment
Salim, S., Ahmad, F. A., Banu, A., & Mohammad, F. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.10.013 · Cited by 124
Gut-brain and brain-gut axis in Parkinson’s disease models: effects of a uridine and fish oil diet
Perez-Pardo, P., Dodiya, H. B., Broersen, L. M., Douna, H., van Wijk, N., Lopes da Silva, S., Garssen, J., Keshavarzian, A., & Kraneveld, A. D. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1294555 · Cited by 111
The Search for Environmental Causes of Parkinson’s Disease: Moving Forward
Chen, H., & Ritz, B. R. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-181493 · Cited by 113
Self-citationSleep and risk of parkinsonism and Parkinson’s disease: a population-based study
Lysen, T. S., Darweesh, S. K. L., Ikram, M. K., Luik, A. I., & Ikram, M. A. (2019) · Brain · doi:10.1093/brain/awz113 · Cited by 108
Potential roles of gut microbiota and microbial metabolites in Parkinson’s disease
Zheng, S.-Y., Li, H.-X., Xu, R.-C., Miao, W.-T., Dai, M.-Y., Ding, S.-T., & Liu, H.-D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101347 · Cited by 101
Prevalence of Non‐Motor Symptoms and Non‐Motor Fluctuations in Parkinson's Disease Using the MDS‐NMS
Rodríguez‐Blázquez, C., Schrag, A. E., Rizos, A., Chaudhuri, К. R., Martínez‐Martín, P., & Weintraub, D. A. (2020) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13122 · Cited by 95
Parkinson's disease: From bench to bedside
Draoui, A., Hiba, O. E., Aimrane, A., Khiat, A. E., & Gamrani, H. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2019.11.002 · Cited by 82
Heart Rate Variability Analyses in Parkinson’s Disease: A Systematic Review and Meta-Analysis
Heimrich, K. G., Lehmann, T., Schlattmann, P., & Prell, T. (2021) · Brain Sciences · doi:10.3390/brainsci11080959 · Cited by 82
The Endotoxin Hypothesis of Parkinson's Disease
Brown, G. C., Camacho, M., & Williams‐Gray, C. H. (2023) · Movement Disorders · doi:10.1002/mds.29432 · Cited by 85
Clinical implications of gastric complications on levodopa treatment in Parkinson’s disease
Pfeiffer, R. F., Isaacson, S. H., & Pahwa, R. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.05.001 · Cited by 77
Redefining Non-Motor Symptoms in Parkinson’s Disease
Peña-Zelayeta, L., Delgado-Minjares, K. M., Villegas-Rojas, M. M., León‐Arcia, K., Santiago-Balmaseda, A., Andrade-Guerrero, J., Pérez-Segura, I., Ortega‐Robles, E., Soto-Rojas, L. O., & Arias-Carrión, Ó. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15050172 · Cited by 80
Early constipation predicts faster dementia onset in Parkinson’s disease
Camacho, M., Macleod, A. D., Maple‐Grødem, J., Evans, J., Breen, D. P., Cummins, G. A., Wijeyekoon, R., Greenland, J. C., Alves, G. W., Tysnes, O., et al. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00191-w · Cited by 71
Nosrani, E. A., Tamtaji, O. R., Alibolandi, Z., Sarkar, P., Ghazanfari, M., Tameh, A. A., Taghizadeh, M., Banikazemi, Z., Hadavi, R., & Taheri, M. N. (2020) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2020.1833917 · Cited by 70
Sleep Disturbances in the Prodromal Stage of Parkinson Disease
Al‐Qassabi, A., Fereshtehnejad, S., & Postuma, R. B. (2017) · Current Treatment Options in Neurology · doi:10.1007/s11940-017-0458-1 · Cited by 68
Velioğlu, H. A., Hanoğlu, L., Bayraktaroğlu, Z., Toprak, G., Güler, E. M., Bektay, M. Y., Burnaz, O. M., & Yuluğ, B. (2021) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2021.107410 · Cited by 68
Constipation in Parkinson’s Disease: A Systematic Review and Meta-Analysis
Yao, L., Liang, W., Chen, J., Wang, Q., & Huang, X. (2022) · European Neurology · doi:10.1159/000527513 · Cited by 63
Self-citationNatural Phenolic Compounds with Neuroprotective Effects
Tavan, M., Hanachi, P., Cádiz‐Gurrea, M. D. L. L., Segura‐Carretero, A., & Mirjalili, M. H. (2023) · Neurochemical Research · doi:10.1007/s11064-023-04046-z · Cited by 66
Maeda, T., Shimo, Y., Chiu, S., Yamaguchi, T., Kashihara, K., Tsuboi, Y., Nomoto, M., Hattori, N., Watanabe, H., & Saiki, H. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.02.024 · Cited by 63
Prevalence of Prodromal Symptoms of Parkinson’s Disease in the Late Middle-Aged Population
Roos, D. S., Klein, M., Deeg, D. J. H., Doty, R. L., & Berendse, H. W. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-213007 · Cited by 61
The Epidemiology of Nonmotor Symptoms in Parkinson's Disease (Cohort and Other Studies)
Катунина, Е. А., & Titova, N. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.012 · Cited by 60
Advanced Parkinson’s or “complex phase” Parkinson’s disease? Re-evaluation is needed
Titova, N., Martínez‐Martín, P., Катунина, Е. А., & Chaudhuri, К. R. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1799-3 · Cited by 58
Regulation and roles of mitophagy at synapses
Palikaras, K., & Tavernarakis, N. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111216 · Cited by 60
Constipation and risk of Parkinson’s disease: A Danish population-based cohort study
Svensson, E., Henderson, V. W., Borghammer, P., Horváth–Puhó, E., & Sørensen, H. T. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.05.016 · Cited by 57
A scoping review of neurodegenerative manifestations in explainable digital phenotyping
Alfalahi, H., Dias, S. B., Khandoker, A. H., Chaudhuri, К. R., & Hadjileontiadis, L. J. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00494-0 · Cited by 58
Wang, Y., Du, W., Hu, X., Yu, X., Guo, C., Jin, X., & Wang, W. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.08.009 · Cited by 58
Singh, S., & Kumar, P. (2017) · Neuroscience Research · doi:10.1016/j.neures.2017.10.006 · Cited by 56
Singh, T., Jiao, Y., Ferrando, L. M., Yablonska, S., Li, F., Horoszko, E. C., Lacomis, D., Friedlander, R. M., & Carlisle, D. L. (2021) · Scientific Reports · doi:10.1038/s41598-021-97928-7 · Cited by 55
A Narrative Review of Psychobiotics: Probiotics That Influence the Gut–Brain Axis
Ķimse, L., Reinis, A., Miķelsone-Jansone, L., Gintere, S., & Krūmiņa, A. (2024) · Medicina · doi:10.3390/medicina60040601 · Cited by 56
Hyposmia as a Predictive Marker of Parkinson’s Disease: A Systematic Review and Meta-Analysis
Sui, X., Zhou, C., Li, J., Chen, L., Yang, X., & Li, F. (2019) · BioMed Research International · doi:10.1155/2019/3753786 · Cited by 53
Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson’s Disease
Perez‐Pardo, P., Hartog, M., Garssen, J., & Kraneveld, A. D. (2017) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-017-0129-2 · Cited by 53
Gut Microbiota Approach—A New Strategy to Treat Parkinson’s Disease
Liu, J., Xu, F., Nie, Z., & Shao, L. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.570658 · Cited by 52
Accurate Coil Positioning is Important for Single and Paired Pulse TMS on the Subject Level
de Goede, A. A., ter Braack, E. M., & van Putten, M. J. A. M. (2018) · Brain Topography · doi:10.1007/s10548-018-0655-6 · Cited by 50
Malaty, I. A., Martínez‐Martín, P., Chaudhuri, К. R., Odin, P., Škorvánek, M., Shahed, J. J., Soileau, M. J., Lindvall, S., Domingos, J., Jones, S. C., et al. (2022) · BMC Neurology · doi:10.1186/s12883-022-02560-1 · Cited by 50
Neutrophil to lymphocyte ratio in parkinson’s disease: a systematic review and meta-analysis
Hosseini, S., Shafiabadi, N., Khanzadeh, M., Ghaedi, A., Ghorbanzadeh, R., Azarhomayoun, A., Bazrgar, A., Pezeshki, J., Bazrafshan, H., & Khanzadeh, S. (2023) · BMC Neurology · doi:10.1186/s12883-023-03380-7 · Cited by 49
The impact of nonmotor symptoms on quality of life in patients with Parkinson's disease in Taiwan
Liu, W.-M., Wu, R., Lin, C., Tai, C., Yu, R., & Lin, R.-J. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s88968 · Cited by 49
Quantification Analysis of Sleep Based on Smartwatch Sensors for Parkinson’s Disease
Ko, Y.-F., Kuo, P.-H., Wang, C.-F., Chen, Y.-J., Chuang, P.-C., Li, S.-Z., Chen, B., Yang, F.-C., Lo, Y., Yang, Y., et al. (2022) · Biosensors · doi:10.3390/bios12020074 · Cited by 48
Neuropathology of Nonmotor Symptoms of Parkinson's Disease
Jellinger, K. A. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.005 · Cited by 50
A literature review of online handwriting analysis to detect Parkinson’s disease at an early stage
Aouraghe, I., Khaissidi, G., & Mrabti, M. (2022) · Multimedia Tools and Applications · doi:10.1007/s11042-022-13759-2 · Cited by 49
Environmental triggers of Parkinson's disease – Implications of the Braak and dual-hit hypotheses
Chen, H., Wang, K., Scheperjans, F., & Killinger, B. A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105601 · Cited by 45
Self-citationRosch, J. G., Winter, H., DuRoss, A. N., Sahay, G., & Sun, C. (2018) · Colloids and Interface Science Communications · doi:10.1016/j.colcom.2018.12.002 · Cited by 44
Christensen, L. F. B., Jensen, K. F., Nielsen, J., Vad, B. S., Christiansen, G., & Otzen, D. E. (2019) · ACS Omega · doi:10.1021/acsomega.8b03590 · Cited by 45
Prajapati, S. K., Garabadu, D., & Krishnamurthy, S. (2017) · Neurotoxicity Research · doi:10.1007/s12640-016-9693-6 · Cited by 44
Non motor symptoms in progressive supranuclear palsy: prevalence and severity
Radicati, F. G., Martín, P. M., FOSSATI, C., Chaudhuri, К. R., Torti, M., Rodríguez‐Blázquez, C., Vacca, L., & Stocchi, F. (2017) · npj Parkinson s Disease · doi:10.1038/s41531-017-0037-x · Cited by 43
Therapeutic potential of stem cells for treatment of neurodegenerative diseases
Ahmadian-Moghadam, H., Sadat‐Shirazi, M., & Zarrindast, M. (2020) · Biotechnology Letters · doi:10.1007/s10529-020-02886-1 · Cited by 44
Additive Effects of Levodopa and a Neurorestorative Diet in a Mouse Model of Parkinson’s Disease
Perez‐Pardo, P., Broersen, L. M., Kliest, T., van Wijk, N., Attali, A., Garssen, J., & Kraneveld, A. D. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00237 · Cited by 40
Hunn, B. H. M., Vingill, S., Threlfell, S., Alegre-Abarrategui, J., Magdelyns, M., Deltheil, T., Bengoa-Vergniory, N., Oliver, P. L., Cioroch, M., Doig, N. M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.029 · Cited by 38
Who Can Diagnose Parkinson's Disease First? Role of Pre-motor Symptoms
Rodríguez‐Violante, M., Zerón-Martínez, R., Cervantes‐Arriaga, A., & Corona, T. (2017) · Archives of Medical Research · doi:10.1016/j.arcmed.2017.08.005 · Cited by 41
The Challenge and Opportunity to Diagnose Parkinson's Disease in Midlife
Kilzheimer, A., Hentrich, T., Burkhardt, S., & Schulze-Hentrich, J. M. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01328 · Cited by 41
Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's disease
Liu, R., Umbach, D. M., Tröster, A. I., Huang, X., & Chen, H. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.02.001 · Cited by 37
Self-citationIrritable bowel syndrome and Parkinson’s disease risk: register-based studies
Liu, B., Sjölander, A., Pedersen, N. L., Ludvigsson, J. F., Chen, H., Fang, F., & Wirdefeldt, K. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-020-00145-8 · Cited by 37
Self-citationThe Gastrointestinal Dysfunction Scale for Parkinson's Disease
Camacho, M., Greenland, J. C., & Williams‐Gray, C. H. (2021) · Movement Disorders · doi:10.1002/mds.28675 · Cited by 37
Deidda, G., & Biazzo, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.753915 · Cited by 37
Relationship among Parkinson’s disease, constipation, microbes, and microbiological therapy
Yuan, X.-Y., Chen, Y., & Liu, Z. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i3.225 · Cited by 35
Darweesh, S. K. L., Wolters, F. J., Albert Hofman, D., Stricker, B. H. C., Koudstaal, P. J., & Ikram, M. A. (2016) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw122 · Cited by 35
Epidemiological study of elderly constipation in Beijing
Zhang, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i47.13368 · Cited by 32
Wang, K., Zhang, C., Zhang, B., Li, G., Shi, G., Cai, Q., & Huang, M. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.114152 · Cited by 33
Elbaz, A. (2016) · Revue Neurologique · doi:10.1016/j.neurol.2016.07.001 · Cited by 32
Nanoparticles of chosen noble metals as reactive oxygen species scavengers
Ivanova, P., Dzięgielewski, K., Drozd, M., Skorupska, S., Grabowska‐Jadach, I., & Pietrzak, M. (2020) · Nanotechnology · doi:10.1088/1361-6528/abc19f · Cited by 30
Polymeric nanoparticles for RNA delivery
Jiang, X., Abedi, K., & Shi, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822425-0.00017-8 · Cited by 33
Variation in Recent Onset Parkinson’s Disease: Implications for Prodromal Detection
Swallow, D. M. A., Lawton, M., Grosset, K. A., Malek, N., Smith, C. R., Bajaj, N. P. S., Barker, R. A., Ben‐Shlomo, Y., Burn, D. J., Foltynie, T., et al. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-150741 · Cited by 29
Gan, J., Wan, Y., Shi, J., Zhou, M., Lou, Z., & Liu, Z. (2018) · BMC Neurology · doi:10.1186/s12883-018-1034-3 · Cited by 33
Yang, H., Shao, Y., Hu, Y., Jin, Q., Wang, P., Tian, L., Ni, Y., Li, S., Al‐Nusaif, M., Liu, C., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70003 · Cited by 33
Li, Y.-J., Leong, I.-I., Fan, J.-Q., Yan, M.-Y., Liu, X., Lu, W.-J., Chen, Y.-Y., Tan, W.-Q., Wang, Y.-T., & Zhuang, L.-X. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1126080 · Cited by 26
The Changing Landscape of Parkinson Epidemiologic Research
Chen, H. (2017) · Journal of Parkinson s Disease · doi:10.3233/jpd-171238 · Cited by 29
Self-citationConstipation in Parkinson's Disease
Quigley, E. M. M. (2023) · Seminars in Neurology · doi:10.1055/s-0043-1771457 · Cited by 25
Phillips, K. A., Ross, C. N., Spross, J., Cheng, C. J. A., Izquierdo, A. M., Biju, K. C., Chen, C., Li, S., & Tardif, S. D. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.02.010 · Cited by 25
Behl, T., Kaur, G., Sehgal, A., Singh, S., Bhatia, S., Al‐Harrasi, A., Zengin, G., BUNGAU, S. G., Munteanu, M. A., Brisc, M. C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084045 · Cited by 25
Olfactory dysfunction as potential biomarker in neurodegenerative diseases: a narrative review
Cleene, N. D., Schwarzová, K., Labrecque, S., Cerejo, C., Djamshidian, A., Seppi, K., & Heim, B. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1505029 · Cited by 23
Stroke and Coronary Artery Disease Are Associated With Parkinson’s Disease
Li, Q., Wang, C., Tang, H., Chen, S., & Ma, J. (2018) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2018.56 · Cited by 23
Lu, H., Shen, Q., Xie, D., Zhao, Q., & Xu, Y. (2019) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01354-9 · Cited by 23
Park, S. J., Kim, K. W., & Lee, E. J. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00994 · Cited by 27
REM sleep behavior disorder was associated with Parkinson’s disease: a community-based study
Ma, J., Hou, M.-M., Tang, H.-D., Gao, X., Liang, L., Zhu, L.-F., Zhou, Y., Sheng-yu, Z. H. A., Cui, S.-S., Du, J.-J., et al. (2016) · BMC Neurology · doi:10.1186/s12883-016-0640-1 · Cited by 23
Litteljohn, D., Rudyk, C., Dwyer, Z., Farmer, K., Fortin, T., & Hayley, S. P. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.09.002 · Cited by 23
Hydrogels: potential aid in tissue engineering—a review
Senthilkumar, M. B., Priyanka, G., Rajalakshmi, S., Sankar, R., Sabreen, T., & Ravindran, J. (2021) · Polymer Bulletin · doi:10.1007/s00289-021-03864-x · Cited by 22
Mortality from Parkinson’s disease in China: Findings from a five-year follow up study in Shanghai
Wang, G., Li, X., Hu, Y., Cheng, Q., Wang, C., Xiao, Q., Liu, J., Ma, J., Zhou, H., Pan, J., et al. (2015) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2015.49 · Cited by 22
Enhancing Targeted Drug Delivery through Cell‐Specific Endosomal Escape
Chen, P., & Cabral, H. (2024) · ChemMedChem · doi:10.1002/cmdc.202400274 · Cited by 21
Association between Parkinson’s disease and the faecal eukaryotic microbiota
Weis, S., Meisner, A., Schwiertz, A., Unger, M. M., Becker, A., Fassbender, K. C., Schnell, S., Schäfer, K., & Egert, M. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00244-0 · Cited by 21
A Critical Analysis of Intestinal Enteric Neuron Loss and Constipation in Parkinson’s Disease
O’Day, C., Finkelstein, D. I., Diwakarla, S., & McQuade, R. M. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223262 · Cited by 20
Metadata
- Authors
- Chen, H., Zhao, E. J., Zhang, W., Lu, Y., Liu, R., Huang, X., Ciesielski-Jones, A. J., Justice, M. A., Cousins, D. S., & Peddada, S.
- Affiliations
- National Institutes of Health (US)
- Social and Scientific Systems (United States) (US)
- Pennsylvania State University (US)
- National Institute of Environmental Health Sciences (US)
- Corresponding author
- Chen, Honglei
- ORCID
- Venue
- Translational Neurodegeneration
- Published
- 2015-01-08
- Volume
- 4
- Issue
- 1
- Pages
- 1-1
- ISSN
- 2047-9158 (ISSN-L)
- PMC
- PMC4322463
- OpenAlex
- W2126909058
- Cited by
- 212
- References
- 40
- Citations by year
- 2026: 11 · 2025: 22 · 2024: 16 · 2023: 21 · 2022: 20 · 2021: 26 · 2020: 20 · 2019: 16 · 2018: 21 · 2017: 28 · 2016: 7 · 2015: 4
- FWCI
- 14.10
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Translational Neurodegeneration (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1z01es101986-03, Z01-ES101986)
- National Institute of Neurological Disorders and Stroke (U01NS082151)
- National Institute of Environmental Health Sciences
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- Parkinson's disease, non-motor symptoms, hyposmia, constipation, REM sleep behavior disorder, excessive daytime sleepiness, depression, anxiety, symptom prevalence, preclinical Parkinson's disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review